000120551 001__ 120551
000120551 005__ 20240228145452.0
000120551 0247_ $$2doi$$a10.1038/cddis.2017.49
000120551 0247_ $$2pmid$$apmid:28252645
000120551 0247_ $$2pmc$$apmc:PMC5386552
000120551 0247_ $$2altmetric$$aaltmetric:19644454
000120551 037__ $$aDKFZ-2017-00980
000120551 041__ $$aeng
000120551 082__ $$a570
000120551 1001_ $$0P:(DE-He78)08b90069c7cb74d14939106d2a1fac13$$aThole, Theresa$$b0$$eFirst author
000120551 245__ $$aNeuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival.
000120551 260__ $$aLondon [u.a.]$$bNature Publishing Group$$c2017
000120551 3367_ $$2DRIVER$$aarticle
000120551 3367_ $$2DataCite$$aOutput Types/Journal article
000120551 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1533035687_22092
000120551 3367_ $$2BibTeX$$aARTICLE
000120551 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000120551 3367_ $$00$$2EndNote$$aJournal Article
000120551 520__ $$aThe number of long-term survivors of high-risk neuroblastoma remains discouraging, with 10-year survival as low as 20%, despite decades of considerable international efforts to improve outcome. Major obstacles remain and include managing resistance to induction therapy, which causes tumor progression and early death in high-risk patients, and managing chemotherapy-resistant relapses, which can occur years after the initial diagnosis. Identifying and validating novel therapeutic targets is essential to improve treatment. Delineating and deciphering specific functions of single histone deacetylases in neuroblastoma may support development of targeted acetylome-modifying therapeutics for patients with molecularly defined high-risk neuroblastoma profiles. We show here that HDAC11 depletion in MYCN-driven neuroblastoma cell lines strongly induces cell death, mostly mediated by apoptotic programs. Genes necessary for mitotic cell cycle progression and cell division were most prominently enriched in at least two of three time points in whole-genome expression data combined from two cell systems, and all nine genes in these functional categories were strongly repressed, including CENPA, KIF14, KIF23 and RACGAP1. Enforced expression of one selected candidate, RACGAP1, partially rescued the induction of apoptosis caused by HDAC11 depletion. High-level expression of all nine genes in primary neuroblastomas significantly correlated with unfavorable overall and event-free survival in patients, suggesting a role in mediating the more aggressive biological and clinical phenotype of these tumors. Our study identified a group of cell cycle-promoting genes regulated by HDAC11, being both predictors of unfavorable patient outcome and essential for tumor cell viability. The data indicate a significant role of HDAC11 for mitotic cell cycle progression and survival of MYCN-amplified neuroblastoma cells, and suggests that HDAC11 could be a valuable drug target.
000120551 536__ $$0G:(DE-HGF)POF3-317$$a317 - Translational cancer research (POF3-317)$$cPOF3-317$$fPOF III$$x0
000120551 588__ $$aDataset connected to CrossRef, PubMed,
000120551 7001_ $$0P:(DE-HGF)0$$aLodrini, Marco$$b1
000120551 7001_ $$0P:(DE-HGF)0$$aFabian, Johannes$$b2
000120551 7001_ $$0P:(DE-HGF)0$$aWuenschel, Jasmin$$b3
000120551 7001_ $$aPfeil, Sebastian$$b4
000120551 7001_ $$00000-0003-1277-310X$$aHielscher, Thomas$$b5
000120551 7001_ $$0P:(DE-He78)bb6a7a70f976eb8df1769944bf913596$$aKopp-Schneider, Annette$$b6$$udkfz
000120551 7001_ $$aHeinicke, Ulrike$$b7
000120551 7001_ $$aFulda, Simone$$b8
000120551 7001_ $$0P:(DE-He78)143af26de9d57bf624771616318aaf7c$$aWitt, Olaf$$b9
000120551 7001_ $$aEggert, Angelika$$b10
000120551 7001_ $$aFischer, Matthias$$b11
000120551 7001_ $$0P:(DE-HGF)0$$aDeubzer, Hedwig E$$b12$$eLast author
000120551 773__ $$0PERI:(DE-600)2541626-1$$a10.1038/cddis.2017.49$$gVol. 8, no. 3, p. e2635 -$$n3$$pe2635 $$tCell death & disease$$v8$$x2041-4889$$y2017
000120551 909CO $$ooai:inrepo02.dkfz.de:120551$$pVDB
000120551 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)08b90069c7cb74d14939106d2a1fac13$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000120551 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000120551 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000120551 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000120551 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bb6a7a70f976eb8df1769944bf913596$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000120551 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)143af26de9d57bf624771616318aaf7c$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000120551 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b12$$kDKFZ
000120551 9131_ $$0G:(DE-HGF)POF3-317$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTranslational cancer research$$x0
000120551 9141_ $$y2017
000120551 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCELL DEATH DIS : 2015
000120551 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000120551 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000120551 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000120551 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000120551 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000120551 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000120551 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000120551 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000120551 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000120551 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000120551 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000120551 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCELL DEATH DIS : 2015
000120551 9201_ $$0I:(DE-He78)G340-20160331$$kG340$$lKKE Pädiatrische Onkologie$$x0
000120551 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lBiostatistik$$x1
000120551 9201_ $$0I:(DE-He78)L101-20160331$$kL101$$lDKTK Heidelberg$$x2
000120551 9201_ $$0I:(DE-He78)L501-20160331$$kL501$$lDKTK Frankfurt$$x3
000120551 9201_ $$0I:(DE-He78)L201-20160331$$kL201$$lDKTK Berlin$$x4
000120551 980__ $$ajournal
000120551 980__ $$aVDB
000120551 980__ $$aI:(DE-He78)G340-20160331
000120551 980__ $$aI:(DE-He78)C060-20160331
000120551 980__ $$aI:(DE-He78)L101-20160331
000120551 980__ $$aI:(DE-He78)L501-20160331
000120551 980__ $$aI:(DE-He78)L201-20160331
000120551 980__ $$aUNRESTRICTED